Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Avastin
Company Monitoring Page for Avastin
latest headlines for company on cafepharma
Roche gets European approval for Tecentriq combo vs. lung cancer
Reuters
Fri, 03/8/19 - 10:12 am
Tags:
Roche
,
Europe
,
Tecentriq
,
Avastin
,
lung cancer
,
metastatic non-squamous non-small cell lung cancer
Top 10 drugs losing exclusivity in 2019
Fierce Pharma
Tue, 03/5/19 - 09:40 am
Tags:
market exclusivity
,
patents
,
Rituxan
,
Lyrica
,
Herceptin
,
Avastin
,
Epclusa
,
Harvoni
,
Pfizer
,
Roche
,
Gilead Sciences
,
Amgen
,
GSK
,
Allergan
,
Individor
Genentech Scores FDA Approval for Tecentriq and Avastin Combo in NSCLC
BioSpace
Fri, 12/7/18 - 11:59 am
Tags:
Genentech
,
FDA
,
Tecentriq
,
Avastin
,
non-squamous cell non-small cell lung cancer
One more shot at slowing Keytruda’s first-line lung cancer domination
EP Vantage
Wed, 11/28/18 - 10:12 am
Tags:
Keytruda
,
Merck
,
Roche
,
Tecentriq
,
Avastin
,
lung cancer
Novartis, Bayer consider appeal as court says Avastin can be used in AMD
Pharmaforum
Mon, 09/24/18 - 03:37 pm
Tags:
UK
,
Roche
,
Avastin
,
wet age-related macular degeneration
,
Novartis
,
Bayer
In a rare delay for the fast PD-1/L1 crowd, FDA tells Roche to wait on its Tecentriq/Avastin triple for lung cancer
Endpoints
Thu, 09/6/18 - 11:42 am
Tags:
Genentech
,
Roch
,
Tecentriq
,
Avastin
,
lung cancer
,
FDA
Roche's Avastin could get a boost with Tecentriq's second lung cancer win this week
Fierce Pharma
Mon, 03/26/18 - 10:37 pm
Tags:
Roche
,
Avastin
,
Tecentriq
,
lung cancer
AbbVie blockbuster leads 2017 top drug sales; Roche cancer meds follow closely
S&P Global
Wed, 03/14/18 - 09:38 pm
Tags:
AbbVie
,
Roche
,
Humira
,
Rituxan
,
Herceptin
,
Avastin
Failure in pivotal PhIII brain cancer trial drags Israel’s VBL Therapeutics down
Endpoints
Thu, 03/8/18 - 09:39 am
Tags:
clinical trials
,
VBL Therapeutics
,
VB-111
,
Roche
,
Avastin
,
glioblastoma
Roche CEO Schwan concedes challenges as ‘highly, highly profitable’ drugs fall to biosimilar rivals
Fierce Pharma
Tue, 01/16/18 - 06:56 pm
Tags:
Roche
,
Pharma CEOs
,
Severin Schwan
,
biosimilars
,
Herceptin
,
Rituxan
,
Avastin
The 2018 biosimilar litigation landscape: A primer
BioPharma Dive
Sun, 12/17/17 - 11:35 am
Tags:
biosimilars
,
FDA
,
Neupogen
,
Neulasta
,
Remicade
,
Epogen
,
Enbreal
,
Humira
,
Avastin
,
Herceptin
Roche's Fight With Pfizer May Be Just The Beginning
Forbes
Mon, 12/11/17 - 11:31 pm
Tags:
Roche
,
Pfizer
,
Herceptin
,
biosimilars
,
cancer
,
Avastin
,
Rituxan
Roche, Novartis' Italian heads risk trial for alleged market rigging: sources
Yahoo/Reuters
Fri, 12/8/17 - 10:00 am
Tags:
Roche
,
Novartis
,
Italy
,
Avastin
,
Lucentis
,
marketing manipulation
FDA Clears Biotech Drug Copycats, But Buying Them Isn’t So Easy
Bloomberg
Mon, 09/18/17 - 09:41 am
Tags:
FDA
,
Avastin
,
biosimilars
,
Roche
FDA commish cheers on biosimilars as Amgen, Allergan score OK for knockoff of Roche’s Avastin
Endpoints
Fri, 09/15/17 - 09:14 am
Tags:
FDA
,
Scott Gottlieb
,
Amgen
,
Allergan
,
biosimilars
,
Mvasi
,
Roche
,
Avastin
Key FDA Regulatory Events to Watch Out for in Sep 2017
Yahoo/Zacks.com
Mon, 09/4/17 - 10:31 pm
Tags:
FDA
,
Mylan Labs
,
Herceptin
,
biosimilars
,
trastuzumab
,
Shingrix
,
GSK
,
Pfizer
,
Sutent
,
PTC Therapeutics
,
Translarna
,
Amgen
,
Allergan
,
Avastin
Poor test results for Roche cloud growth prospects
Yahoo/Reuters
Wed, 07/19/17 - 09:54 am
Tags:
Roche
,
biosimilars
,
Rituxan
,
Herceptin
,
Avastin
The biosimilar pack is growing around Roche’s all-star trio, looking to rip into a $21B franchise
Endpoints
Wed, 07/12/17 - 10:36 am
Tags:
Roche
,
biosimilars
,
Avastin
,
Herceptin
,
ABP 215
,
Amgen
,
MYL-14010
,
Mylan Labs
,
Rituxan
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)
Motley Fool
Fri, 06/30/17 - 11:06 am
Tags:
prescription data
,
Sanofi
,
Lantus
,
Roche
,
Herceptin
,
Avastin
,
Celgene
,
Revlimid
,
JNJ
,
Merck
,
Remicade
,
Biogen
,
Rituxan
,
Amgen
,
Enbrel
,
Gilead Sciences
,
Harvoni
,
AbbVie
,
Humira
Amid sales growth, Roche plans defense from biosimilar threats
BioPharma Dive
Fri, 04/28/17 - 10:30 am
Tags:
Roche
,
biosimilars
,
Rituxan
,
Herceptin
,
Avastin
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.